ADORA2A and cancer: Many studies have revealed that A2AR, induced by adenosine, impedes the function and proliferation of T and NK cells; in contrast, A2AR stimulates Foxp3-expressing Tregs, which results in immune evasion of cancer and leads to poor clinical outcome [89,91,92].